AAVantgarde Bio

AAVantgarde Bio operates in the biotechnology research industry, focusing on pioneering treatments for Stargardt disease and Usher 1B by addressing the root causes of these conditions. The company leverages advanced technologies in biotechnology, immunology, and genetics, as well as expertise in pharmaceuticals and antibodies. With a strong emphasis on innovation, AAVantgarde Bio also engages in the management of patents and intellectual property. Its efforts reflect a commitment to developing effective therapeutic solutions in the field of genetic disorders.